Yahoo Movies Sorrento Distributes Dividend Confirmation Statements to 146 Brokerage Firms and Provides Specific Instruction to Continental Stock Transfer & Trust Company Regarding the Dividend of Scilex Holding Company Common Stock
SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today distributed dividend confirmation statements to 146 brokerage firms regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) held by Sorrento. These statements, which contain the account numbers and amount of Scilex dividend shares, were previously mailed out by Continental Stock Transfer & Trust Company.
The dividend confirmation statements are being distributed on behalf of Sorrento and Scilex to notify each brokerage firm of Sorrento’s previously announced stock dividend (the “Dividend”) consisting of an aggregate of 76,000,000 shares (the “Dividend Stock”) of common stock of Scilex held by Sorrento to record holders of (i) Sorrento’s common stock (the “Record Common Holders”) as of the close of business on January 9, 2023 (the “Record Date”), and (ii) certain warrants to purchase Sorrento common stock (which have or may have the right to participate in the Dividend pursuant to the terms of their respective warrants).
According to Sorrento’s estimates, approximately 60 million or more shares of Sorrento common stock were sold “short” as of the Record Date. In the event the shares of Sorrento common stock were held through a brokerage firm, bank, dealer or other similar organization and were sold “short” as of the Record Date, holders should consult with their financial advisor, broker or other agent immediately to determine whether they may also be deemed “short” Scilex common stock as a result of the Dividend, as well as any obligations required for you to cover your “short” position(s). Please note that “naked short” sales or “naked short” positions in any Sorrento common stock may constitute a violation of the U.S. Securities and Exchange Commission Regulation SHO.
Each Record Common Holder is entitled to receive 0.1410127 of a share of Scilex common stock for each one share of Sorrento common stock held by such Record Common Holder as of the close of business on the Record Date. The payment date for the Dividend was January 19, 2023. The resulting fewer number of shares of Scilex common stock that will be available to trade could cause the trading market of the common stock of Scilex to become less liquid. As noted above, Scilex’s transfer agent, Continental Stock Transfer & Trust Company (“CST”), has already distributed to brokerage firms, as the Record Common Holder (for the benefit of their customers that held Sorrento common stock on the Record Date), a book-entry/DRS transaction confirmation (the “Dividend Confirmation Statement”) reflecting the portion of the Dividend Stock allocated to such firm (for the benefit of their customers that held Sorrento common stock on the Record Date), which Dividend Confirmation Statements were mailed to the addresses on record with The Depository Trust & Clearing Corporation.
In the event that brokerage firms did not receive copies of the Dividend Confirmation Statements, please contact CST immediately. Sorrento and Scilex are requesting that each brokerage firm distribute the Dividend Stock to the actual beneficial owners thereof and to reflect Scilex’s CUSIP number 80880W106 and value of Scilex common stock on each beneficial owner’s brokerage statement.
Sorrento and Scilex have given specific instructions to Scilex’s transfer agent, CST, on how to answer certain inquiries from Record Holders and brokerage firms:
When beneficial holders call CST:
CST will direct the beneficial holders to contact their brokers.
When brokers call CST:
CST needs to confirm with the broker that such broker has received their Dividend Confirmation Statement.
If brokers did not get the Dividend Confirmation Statement, CST will distribute the Dividend Confirmation Statement again to the applicable broker.
CST will communicate to the brokers that Sorrento and Scilex demand that brokers distribute the Scilex common stock to the individual accounts of the beneficial holders.
If brokers refuse to distribute the Scilex common stock, Sorrento and Scilex will work with CST and the beneficial holder in exiting their brokerage accounts out of “street” name and into book entry format with CST so that the beneficial holder becomes the direct holder of record with CST. The beneficial holders will be charged $15 for the exit of such positions from their brokerage accounts.
To obtain a copy of the Dividend Confirmation Statement and to have the Dividend Stock reflected on such Dividend Confirmation Statement further distributed to the actual beneficial owners thereof, please contact Scilex’s transfer agent, CST, by phone or email at:
Continental Stock Transfer & Trust Company
Telephone Number: 800-509-5586
Email Address: cstmail@continentalstock.com
Broker List
Broker Name | Broker Address |
| Broker Name | Broker Address |
ABN AMRO CLEARING CHICAGO LLC | 175 WEST JACKSON BLVD. CHICAGO | Albert Fried & Company LLC | 45 BROADWAY, 24TH FLOOR | |
AMALGAMATED BANK | 275 7TH AVENUE NEW YORK | AMERICAN ENTERPRISE INVESTMENT SERVICES INC. | 682 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS |
Broker Name | Broker Address |
| Broker Name | Broker Address |
APEX CLEARING CORPORATION | 2 GATEWAY | BANK OF AMERICA, NA/GWIM TRUST OPERATIONS | 901 MAIN STREET | |
BANK OF NEW YORK MELLON | 111 SANDERS CREEK PARKWAY 2ND FLOOR | BARCLAYS CAPITAL INC. | DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS- MILLER OR ROBERT MENDEZ | |
BARCLAYS CAPITAL INC. | DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZ JERSEY CITY | BMO CAPITAL MARKETS CORP. | 3 2ND STREET | |
BMO HARRIS BANK NA/TRUST | 11270 W PARK PL MILWAUKEE | BMO Nesbitt Burns Inc., Toronto | 250 YONGE STREET, | |
BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME | 100 WEST 33RD STREET | BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME | 100 WEST 33RD STREET | |
BNY MELLON | PO BOX 392002 | BNY MELLON/WEALTH MANAGEMENT | 1 FREEDOM VALLEY DRIVE | |
BNYMELLON | 111 SANDERS CREEK PARKWAY 2ND FLOOR | BNYMELLON/RE BARCLAYS CAPITAL SECURITIES LTD. | ONE WALL STREET NEW YORK |
Broker Name | Broker Address |
| Broker Name | Broker Address |
| NY NEW YORK 13057 US |
|
| |
BNYMELLON/RE CACEIS BANK LUXEMBOURG | 500 Grant St. | BNYMELLON/RE CACEIS BANK, NETHERLANDS | 111 SANDERS CREEK PARKWAY | |
BNYMELLON/RE CHARLES STANLEY AND COMPANY, LIMITED | 111 SANDERS CREEK PARKWAY 2ND FLOOR | BNYMELLON/RE ETF - ISHARES DTC/NSCC | 111 SANDERS CREEK PARKWAY | |
BNYMELLON/RE WINTERFLOOD SECURITIES LTD | 500 Grant St. | 4804 Deer Lake Drive East | ||
4804 Deer Lake Drive East | BOFA | 4804 Deer Lake Drive East | ||
BROWN BROTHERS HARRIMAN & CO. | 140 BROADWAY ATTN: CORPORATE ACTIONS VAULT NEW YORK | BROWN BROTHERS HARRIMAN & CO./ETF | 140 BROADWAY NEW YORK | |
CALDWELL SECURITIES LTD./CDS** | 55 UNIVERSITY AVENUE | CANACCORD GENUITY CORP. | 609 GRANVILLE ST VANCOUVER | |
CANTOR, FITZGERALD & CO. | 135 E 57TH ST 5TH FL | CDS CLEARING AND DEPOSITORY SERVICES INC. | 100 ADELAIDE STREET WEST TORONTO | |
CETERA INVESTMENT SERVICES LLC | 400 FIRST STREET | CHARLES SCHWAB & CO., INC. | 211 MAIN STREET SAN FRANCISCO CA CALIFORNIA |
Broker Name | Broker Address |
| Broker Name | Broker Address |
| MN MINNESOTA 56302-0283 US |
|
| |
CI INVESTMENT SERVICES INC. | 199 BAY STREET | CIBC WORLD MARKETS INC./CDS** | 161 BAY STREET 10 FL | |
CITIBANK, N.A./ETF | 3800 CITIGROUP CENTER | CITIBANK, NATIONAL ASSOCIATION | 3800 CITIBANK CENTER TAMPA BLDG.B FIRST FLOOR ZONE 8 TAMPA | |
CITIGROUP GLOBAL MARKETS, INC. | 580 CROSSPOINT PARKWAY GETZVILLE | CLEAR STREET LLC | 4 World Trade Center, 45th Floor | |
CLEARSTREET IO | 55 BROADWAY | COMMERCE BANK | 922 WALNUT STREET MAIL STOP TBTS-2 KANSAS CITY | |
COR CLEARING LLC | 9300 UNDERWOOD AVE | Credential Securities Inc. | 800-1111 WEST GEORGIA STREET VANCOUVER | |
CREST INTERNATIONAL NOMINEES LIMITED | 33 CANNON STREET LONDON EC4M 5SB GB | CURVATURE SECURITIES, LLC | 39 MAIN STREET CHATHAM | |
D.A. DAVIDSON & CO. | 8 3RD STREET NORTH GREAT FALLS MT MONTANA | DEPOSITO CENTRAL DE VALORES S.A., DEPOSITO DE | AVENIDA APOQUINDO # 4001 |
Broker Name | Broker Address |
| Broker Name | Broker Address |
DESJARDINS SECURITIES INC. | 1253 McGill College 10TH FLOOR MONTREAL QUEBEC | DEUTSCHE BANK AG NY/US CUSTODY | 1251 Avenue Of The Americas | |
DEUTSCHE BANK SECURITIES INC. | 60 WALL STREET | DRIVEWEALTH, LLC | 15 EXCHANGE PLACE | |
E*TRADE CLEARING LLC | HARBORSIDE FINANCIAL CENTER | EDWARD D. JONES & CO., L.P. | 12555 MANCHESTER ROAD | |
EDWARD D. JONES & CO., L.P. | 201 PROGRESS PARKWAY MARYLAND HEIGHTS | FIDELITY CLEARING CANADA | 483 BAY ST. SOUTH TOWER TORONTO | |
FIFTH THIRD BANK | 5001 KINGSLEY DRIVE | FOLIO INVESTMENTS, INC. | 8180 GREENSBORO DRIVE | |
FUTU CLEARING INC. | 12750 Merit Drive | GMP SECURITIES L.P. | 145 KING STREET | |
GOLDMAN, SACHS & CO. LLC | 222 SOUTH MAIN STREET | HAYWOOD SECURITIES INC./CDS** | 200 BURRARD ST WATERFRONT CENTRE SUITE 700 VANCOUVER | |
HILLTOP SECURITIES INC. | 1201 ELM ST. | HRT FINANCIAL LLC | 150 GREENWICH STREET (ATTN: SETTLEMENT) FOUR WORLD TRADE |
Broker Name | Broker Address |
| Broker Name | Broker Address |
|
|
| 57TH FLOOR NEW YORK NY NEW YORK | |
HSBC BANK USA, NA/HSBC CUSTODY & CLEARING SERVICES FOR | 452 FIFTH AVENUE ATTN: HBUS CCS SETTS | HSBC BANK USA, NATIONAL ASSOCIATION | 452 FIFTH AVENUE ATTN: HBUS CCS SETTS | |
INTERACTIVE BROKERS LLC | 2 PICKWICK PLAZA | J.P. MORGAN CHASE BANK NA/FBO BLACKROCK CTF | 1111 POLARIS PARKWAY COLUMBUS OH OHIO | |
J.P. MORGAN CLEARING CORP. | FOUR CHASE METROTECH CENTER | JANNEY MONTGOMERY SCOTT LLC | 1717 ARCH STREET | |
JEFFERIES LLC | 101 HUDSON | JPMORGAN CHASE BANK, NATIONAL ASSOCIATION | FOUR CHASE METROTECH CENTER | |
JPMORGAN CHASE BANK/EUROCLEAR BANK | FOUR CHASE METROTECH CENTER | JPMORGAN CHASE BANK/IA | FOUR CHASE METROTECH CENTER | |
KEYBANK NATIONAL ASSOCIATION | 4900 TIEDEMAN RD BROOKLYN | LAURENTIAN BANK SECURITIES INC. | 1981 MCGILL COLLEGE AVE. SUITE 100 MONTREAL QUEBEC | |
LPL FINANCIAL LLC | 4707 EXECUTIVE DRIVE | MANUFACTURERS AND TRADERS TRUST COMPANY | ONE M&T PLAZA TRUST OPS 8TH FLOOR BUFFALO |
Broker Name | Broker Address |
| Broker Name | Broker Address |
MANULIFE SECURITIES INCORPORATED | 1235 NORTH SERVICE ROAD WEST OAKVILLE | MARSCO INVESTMENT CORPORATION | 101 EISENHOWER PARKWAY ROSELAND | |
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED | 4804 Deer Lake Drive East | MIRAE ASSET SECURITIES (USA) INC./STOCK LOAN CONDUIT ACCOUNT | 810 SEVENTH AVE | |
MIRAE ASSET SECURITIES (USA), INC. | 810 SEVENTH AVE | MITSUBISHI UFJ TRUST & BANKING CORPORATION, NEW YORK | 280 PARK AVE | |
Morgan Stanley | 1300 THAMES STREET | MORGAN STANLEY & CO. LLC | 1300 THAMES ST. BALTIMORE | |
MORGAN STANLEY SMITH BARNEY LLC | 1 NEW YORK PLAZA | MURIEL SIEBERT & CO., INC. | 77 SUMMER STREET | |
NATIONAL FINANCIAL SERVICES LLC | 499 WASHINGTON BOULEVARD | NBCN INC. | 1010 rue De La Gauchetière Mezzanine 100 MONTREAL QUEBEC | |
NOMURA INTERNATIONAL TRUST COMPANY | 309 WEST 49TH STREET | ODLUM BROWN LIMITED | 250 HOWE STREET | |
OPPENHEIMER & CO. INC. | 85 BROAD STREET NEW YORK | PERSHING LLC | 1 PERSHING PLAZA JERSEY CITY |
Broker Name | Broker Address |
| Broker Name | Broker Address |
PHILLIP CAPITAL INC. | 141 W. JACKSON | PI FINANCIAL CORP. | 666 BURRARD ST | |
PNC BANK, NATIONAL ASSOCIATION | 4100 W 150TH STREET | PRINCIPAL BANK | 711 HIGH STREET DES MOINES | |
QUESTRADE INC./CDS** | 5650 YONGE ST., | Raymond James & Associates, Inc. | 880 CARILLON PKWY ST. PETERSBURG | |
RAYMOND JAMES LTD. | 925 WEST GEORGIA STREET SUITE 2200 VANCOUVER | RBC CAPITAL MARKETS, LLC | 60 SOUTH 6TH ST. MINNEAPOLIS MN MINNESOTA 55402 US | |
RBC DOMINION SECURITIES INC | 21 COMMERCE COURT SOUTH 2ND FLOOR TORONTO | RELIANCE TRUST COMPANY | 1100 ABERNATHY RD. | |
RELIANCE TRUST COMPANY | 4900 W. BROWN DEER RD MILWAUKEE WI WISCONSIN 53223 US | ROBERT W. BAIRD & CO. INCORPORATED | 777 E WISCONSIN AVE | |
ROBINHOOD SECURITIES, LLC | 500 COLONIAL CENTER PARKWAY SUITE 100 LAKE MARY FL FLORIDA | SAFRA SECURITIES LLC | 546 5TH AVENUE NEW YORK |
Broker Name | Broker Address |
| Broker Name | Broker Address |
SCOTIA CAPITAL (USA) INC. | 150 KING STREET W | SEI PRIVATE TRUST COMPANY | 1 FREEDOM VALLEY DRIVE | |
SEI PRIVATE TRUST COMPANY | 1 FREEDOM VALLEY DRIVE OAKS | SG AMERICAS SECURITIES, LLC | 480 WASHINGTON BLVD. | |
SSB - BLACKROCK INSTITUTIONAL TRUST | 50 California Street San Francisco | SSB - TRUST CUSTODY | 30 ADELAIDE ST EAST | |
SSB&T CO/CLIENT CUSTODY SERVICES | 1776 HERITAGE DRIVE | STATE STREET BANK & TRUST CO | 16 WALL STREET | |
STATE STREET BANK & TRUST COMPANY / ISHARES EUROPE | 1776 HERITAGE DRIVE | STATE STREET BANK & TRUST/STATE STREET TOTALETF | 1776 Heritage Drive NORTH QUINCY MA MASSACHUSETTS 02717 | |
STATE STREET BANK AND TRUST COMPANY | 30 ADELAIDE ST EAST | STIFEL, NICOLAUS & COMPANY, INCORPORATED | 501 N BROADWAY ST. LOUIS | |
STONEX FINANCIAL INC. | 2 PERIMETER PARK SOUTH SUITE 100 W BIRMINGHAM AL ALABAMA | TD AMERITRADE CLEARING, INC. | 200 S 108TH AVE OMAHA | |
TD WATERHOUSE CANADA INC ATTN: MANDATORY | 77 BLOOR STREET WEST | TEXAS TREASURY SAFEKEEPING TRUST COMPANY | 208 E 10TH ST AUSTIN |
Broker Name | Broker Address |
| Broker Name | Broker Address |
|
|
|
| |
THE BANK OF NEW YORK MELLON | 500 GRANT STREET | THE HUNTINGTON NATIONAL BANK | 7 EASTON OVAL EA4E62 COLUMBUS | |
THE NORTHERN TRUST COMPANY | 333 South Wabash Ave, 32nd Floor Attn: Trade Securities Processing CHICAGO | TRADESTATION SECURITIES, INC | 120 RIVERSIDE PLAZA | |
U.S. BANCORP INVESTMENTS, INC. | 60 LIVINGSTON AVE | U.S. BANK N.A./ETF | 1555 N RIVER CENTER DRIVE MILWAUKEE WI WISCONSIN 53212 | |
U.S. BANK NATIONAL ASSOCIATION | 1555 NORTH RIVERCENTER DRIVE, SUITE 302 | 480 WASHINGTON BLVD. | ||
UBS FINANCIAL SERVICES INC. | 1000 HARBOR BOULEVARD WEEHAWKEN NJ NEW JERSEY | UBS SECURITIES LLC | 677 WASHINGTON BLVD |
Broker Name | Broker Address |
| Broker Name | Broker Address |
UMB BANK, NATIONAL ASSOCIATION | 928 GRAND BLVD KANSAS CITY MO MISSOURI 64106 US | VANGUARD MARKETING CORPORATION | 100 VANGUARD BLVD MALVERN | |
VELOCITY CLEARING, LLC | 1301 Route 36 | VELOX CLEARING LLC | 2400 E. KATELLA AVENUE | |
VIRTU AMERICAS LLC | ONE LIBERTY PLAZA, 165 BROADWAY 5TH FLOOR NEW YORK NY NEW YORK | VISION FINANCIAL MARKETS LLC | 4 HIGH RIDGE PARK SUITE 100 STAMFORD | |
WEDBUSH SECURITIES INC | 1000 WILSHIRE BLVD | WEDBUSH SECURITIES INC. | 1000 WILSHIRE BLVD. | |
WELLS FARGO BANK, N.A./SIG | 733 MARQUETTE AVE 4TH FLOOR MAC N9306-04D MINNEAPOLIS | WELLS FARGO CLEARING SERVICES LLC | 1 NORTH JEFFERSON MAIL CODE: H0006- 094 | |
WELLS FARGO SECURITIES, LLC | 1525 WEST W T HARRIS BLVD CHARLOTTE NC NORTH CAROLINA | WILSON-DAVIS & CO., INC. | 236 SOUTH MAIN STREET |
About Sorrento Therapeutics, Inc.
Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. Sorrento's multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as Abivertinib, next-generation tyrosine kinase inhibitors (“TKIs”), fully human antibodies (“G-MAB™ library”), immuno-cellular therapies (“DAR-T™”), antibody-drug conjugates (“ADCs”), and oncolytic virus (“Seprehvec™”). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including STI-1558, COVI-MSC™; and diagnostic test solutions, including COVIMARK™.
Sorrento's commitment to life-enhancing therapies for patients is also demonstrated by our effort to advance a TRPV1 agonist, non-opioid pain management small molecule, resiniferatoxin (“RTX”), and SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA™), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, and to commercialize ZTlido® (lidocaine topical system) 1.8% for the treatment of postherpetic neuralgia (PHN). RTX has been cleared for a Phase II trial for intractable pain associated with cancer and a Phase II trial in osteoarthritis patients. Positive final results from the Phase III Pivotal Trial C.L.E.A.R. Program for SEMDEXA™, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. ZTlido® was approved by the FDA on February 28, 2018.
For more information visit www.sorrentotherapeutics.com
Media and Investor Relations
Contact: Brian Cooley
Email: mediarelations@sorrentotherapeutics.com
Sorrento® and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc.
G-MAB™, DAR-T™, Seprehvec™, SOFUSA™, COVI-MSC™, COVIMARK™, Ovydso™ and Fujovee™ are trademarks of Sorrento Therapeutics, Inc.
SEMDEXA™ (SP-102) is a trademark of Semnur Pharmaceuticals, Inc. A proprietary name review by the FDA is planned.
ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc. All other trademarks are the property of their respective owners.
©2023 Sorrento Therapeutics, Inc. All Rights Reserved.
